iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by Apexium Financial LP

Apexium Financial LP grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 373.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,040 shares of the financial services provider’s stock after acquiring an additional 7,919 shares during the period. Apexium Financial LP’s holdings in iShares Biotechnology ETF were worth $1,327,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. Aristides Capital LLC acquired a new position in iShares Biotechnology ETF during the second quarter worth $9,180,000. Finally, Sanctuary Advisors LLC purchased a new position in iShares Biotechnology ETF during the second quarter valued at $8,118,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.7 %

Shares of IBB opened at $137.30 on Monday. The stock has a 50 day moving average price of $136.04 and a 200 day moving average price of $141.81. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.